As we approach the annual holiday slow down, we wanted to take a moment to wish everyone in the Ingenuity community the very best this season.
2013 was another inspiring year in the life sciences and one of the most exciting years as a company since our founding 15 years ago. Among the many highlights was our acquisition by QIAGEN in April. We are proud to say that we have made significant progress in integrating the two companies and are working closely together on new solutions for the NGS sample-to-insight workflow as well as the clinical setting.
Some of the many other highlights from this year include:
- Welcoming our new colleagues from CLC bio to the QIAGEN data interpretation team.
- Hosting our first meeting for the new Ingenuity SAB which is made up of a stellar group of healthcare and academic leaders in medical genetics, genomics and bioinformatics.
- Celebrating IPA’s 10th birthday; since its launch, it has been cited in more than 9,800 peer-reviewed journal articles (and counting)!
- Launching the Early Access Program for a new solution that will support molecular pathologists and medical geneticists working with NGS data.
- Meeting the winners of our first ever grant programs: Inaugural Ingenuity Grant Program and Fall Grant Program.
- Working with the National Cancer Institute to make the NCI60 data set freely available for exploration via Variant Analysis.
- Connecting with new and existing colleagues at conferences including AGBT, ASHG, AMP, EUROTOX, and ESHG.
- Sponsoring the Empowered Genome Community which unites people who have had their genomes sequenced and helps make their data scientifically useful through sharing and collaborative interpretation.
- Participating in our Fall Roadshow where we had the enjoyable opportunity to interact with our customers about how they are using Ingenuity products.
- Seeing the first wave of publications in leading peer-reviewed journals citing the use of Variant Analysis
2014 is already shaping up to be another busy and exciting year. Our CTO/CSO Doug Bassett will be speaking at the annual Personalized Medicine World Conference in January; additionally, plans are already underway for an eventful AGBT meeting in Marco Island. We look forward to connecting with you in the new year and learning more about how we can work together to help advance your data interpretation goals.
From all of us at QIAGEN Redwood City, have a safe and relaxing holiday.